Our state-of-the-art laboratory is equipped to conduct a comprehensive array of diagnostic tests, catering to a diverse range of medical needs. From routine blood and urine analyses to advanced molecular diagnostics, our team ensures precise results with a quick turnaround. We specialize in hematology, microbiology, biochemistry, immunology, molecular techniques, histology and cytology. Our advanced tests include PCR assays for infectious disease detection, hormonal assays for endocrine evaluations, and cytological examinations for cancer screenings. With a commitment to accuracy and reliability, our laboratory is the go-to destination for clinicians and patients seeking thorough diagnostic insights.
A Full Blood Count (FBC), also known as a Complete Blood Count (CBC) in some regions, is a common blood test that provides detailed information about the cells in a person's blood. It measures the concentration of white blood cells, red blood cells, and platelets in the blood, as well as the levels of hemoglobin and the hematocrit (the proportion of blood volume occupied by red blood cells). An FBC can offer insights into a person's overall health, detect a variety of disorders such as anemia, infection, and many other diseases. It is a fundamental tool in clinical diagnostics and is frequently used as a part of routine health assessments or to monitor the medical condition and response to treatment in patients.
A reticulocyte count is a diagnostic test that measures the number of reticulocytes (young, immature red blood cells) present in a blood sample. Reticulocytes are released into the bloodstream by the bone marrow before they fully mature into red blood cells. The presence and proportion of reticulocytes in the blood provide valuable insight into the body's rate of red blood cell production. A higher-than-normal reticulocyte count could indicate conditions like hemolytic anemia, recent blood loss, or a response to treatments like iron therapy. Conversely, a lower count may signify bone marrow disorders, certain types of anemia, or chronic illnesses. Evaluating the reticulocyte count aids physicians in diagnosing underlying conditions, assessing the effectiveness of treatments, and monitoring bone marrow function.
A CD4 count is a crucial laboratory test that measures the number of CD4 T lymphocytes (commonly referred to as CD4 cells) in a blood sample. CD4 cells are a type of white blood cell that play a significant role in maintaining the immune system's functionality. These cells are the primary targets of the HIV virus, which attacks and reduces the number of CD4 cells in the body, weakening the immune response. As such, a CD4 count is an essential indicator used to assess the immune system's health, especially in individuals diagnosed with HIV or AIDS. A declining CD4 count often suggests an advancing HIV infection and can guide healthcare professionals in treatment decisions, including the initiation or adjustment of antiretroviral therapy. Monitoring the CD4 count over time is vital for managing HIV and understanding the progression of the disease.
A reticulocyte count is a diagnostic test that measures the number of reticulocytes (young, immature red blood cells) present in a blood sample. Reticulocytes are released into the bloodstream by the bone marrow before they fully mature into red blood cells. The presence and proportion of reticulocytes in the blood provide valuable insight into the body's rate of red blood cell production. A higher-than-normal reticulocyte count could indicate conditions like hemolytic anemia, recent blood loss, or a response to treatments like iron therapy. Conversely, a lower count may signify bone marrow disorders, certain types of anemia, or chronic illnesses. Evaluating the reticulocyte count aids physicians in diagnosing underlying conditions, assessing the effectiveness of treatments, and monitoring bone marrow function.
The T-cell profile refers to a comprehensive analysis of the various subsets of T-cells, which are a type of white blood cell playing a critical role in the immune system. T-cells are responsible for cell-mediated immunity, distinguishing between self and foreign cells to target and eliminate threats such as viruses, bacteria, and cancer cells. A T-cell profile typically evaluates the count, proportion, and functionality of different T-cell subsets, including helper T-cells, cytotoxic T-cells, and regulatory T-cells. Understanding an individual's T-cell profile can provide valuable insights into their immune system's overall health and functionality. It is especially crucial in diagnosing and monitoring conditions like HIV/AIDS, certain types of cancers, autoimmune disorders, and in assessing immune responses post-vaccination or post-infection.
A reticulocyte count is a diagnostic test that measures the number of reticulocytes (young, immature red blood cells) present in a blood sample. Reticulocytes are released into the bloodstream by the bone marrow before they fully mature into red blood cells. The presence and proportion of reticulocytes in the blood provide valuable insight into the body's rate of red blood cell production. A higher-than-normal reticulocyte count could indicate conditions like hemolytic anemia, recent blood loss, or a response to treatments like iron therapy. Conversely, a lower count may signify bone marrow disorders, certain types of anemia, or chronic illnesses. Evaluating the reticulocyte count aids physicians in diagnosing underlying conditions, assessing the effectiveness of treatments, and monitoring bone marrow function.
The clotting profile, comprising the Prothrombin Time (PT) and the Activated Partial Thromboplastin Time (APTT), is a comprehensive diagnostic assessment used to evaluate the coagulation pathways in the blood. PT primarily assesses the extrinsic and common clotting pathways, often used to monitor patients on warfarin therapy or to identify potential liver disorders. In contrast, APTT evaluates the intrinsic and common pathways, making it essential for monitoring heparin therapy and detecting hemophilia or other clotting disorders. Together, PT and APTT offer a holistic view of a patient's hemostatic function, helping clinicians diagnose bleeding disorders, monitor anticoagulant therapies, and determine potential causes of excessive bleeding or thrombosis.
A reticulocyte count is a diagnostic test that measures the number of reticulocytes (young, immature red blood cells) present in a blood sample. Reticulocytes are released into the bloodstream by the bone marrow before they fully mature into red blood cells. The presence and proportion of reticulocytes in the blood provide valuable insight into the body's rate of red blood cell production. A higher-than-normal reticulocyte count could indicate conditions like hemolytic anemia, recent blood loss, or a response to treatments like iron therapy. Conversely, a lower count may signify bone marrow disorders, certain types of anemia, or chronic illnesses. Evaluating the reticulocyte count aids physicians in diagnosing underlying conditions, assessing the effectiveness of treatments, and monitoring bone marrow function.
U&E, which stands for Urea and Electrolytes, combined with Creatinine testing, is a commonly requested blood test that provides crucial insights into kidney function. Urea and creatinine are waste products that the kidneys remove from the blood. Elevated levels of these compounds can indicate reduced kidney function or kidney disease. Electrolytes, including sodium, potassium, and chloride, are vital for a range of physiological processes, including maintaining the body's fluid balance, muscle function, and nerve signaling. An imbalance in these electrolytes can result from various conditions, including dehydration, certain medications, kidney diseases, or other medical conditions. The U&E + Creatinine test, therefore, is essential for assessing renal health, diagnosing kidney disorders, and monitoring the effectiveness of treatments related to kidney diseases.
The Liver Function Test (LFT) is a comprehensive assessment used to gauge the health and functionality of the liver. It measures the levels of various liver enzymes and proteins in the bloodstream, offering insights into the liver's performance and potential indications of liver damage or disease. Enzymes such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP), among others, are typically evaluated. Elevated or reduced levels of these enzymes can indicate conditions like hepatitis, cirrhosis, or liver tumors. Additionally, the test measures bilirubin levels, which can signal liver dysfunction or bile duct obstructions. An LFT is crucial not only for diagnosing liver-related ailments but also for monitoring the liver's response to treatments and medications that might impact its function.
A bone profile, often comprising tests for calcium, magnesium, and phosphate, is a crucial diagnostic tool that evaluates the health and functionality of bones and related metabolic processes. Calcium plays a pivotal role in bone formation, nerve transmission, and muscle contraction. Magnesium, while lesser in quantity in bones, is vital for bone structure and acts as a cofactor in numerous enzymatic reactions. Phosphate, paired with calcium, forms hydroxyapatite, the mineralized component giving bones their rigidity. Abnormal levels of these minerals can indicate conditions such as osteoporosis, kidney diseases, malabsorption syndromes, and parathyroid disorders. Monitoring these elements provides clinicians with insights into bone health, metabolism, and potential underlying conditions.
Cardiac enzymes, including Creatine Kinase (CK), Lactate Dehydrogenase (LDH), Aspartate Transaminase (AST), CK-MB, and Troponins, play a pivotal role in the evaluation of heart function and potential damage. These enzymes and proteins are typically found within heart cells and are essential for its regular functioning. However, when the heart experiences distress, such as during a myocardial infarction (heart attack), these enzymes can leak out into the bloodstream. By measuring the levels of these substances in the blood, clinicians can ascertain the extent of heart muscle damage, the timing of the injury, and potentially predict future cardiac events. Among these, Troponins are particularly sensitive and specific indicators of heart muscle damage and are often the primary markers used in the diagnosis of myocardial infarction. Monitoring cardiac enzyme levels is thus integral to both the diagnosis and management of various heart conditions.
A lipid profile, commonly known as a cholesterol test, is a blood test used to measure the amounts of specific lipids (fats) present in the bloodstream. This essential diagnostic tool assesses an individual's risk of developing cardiovascular diseases. The test typically evaluates several components: low-density lipoprotein (LDL) cholesterol, often referred to as the "bad" cholesterol; high-density lipoprotein (HDL) cholesterol, known as the "good" cholesterol; total cholesterol, which is the sum of LDL and HDL; and triglycerides, a type of fat found in the blood. An imbalance in these components, such as elevated LDL or low HDL levels, can lead to plaque build-up in the arteries, increasing the risk of heart attacks, strokes, and other cardiovascular complications. Regular lipid profile tests are recommended for adults to monitor and manage their heart health effectively.
Iron studies, comprising tests for serum iron, ferritin, and transferrin, provide a comprehensive evaluation of the body's iron status and its ability to transport and store iron. Serum iron measures the amount of circulating iron bound to transferrin, a protein responsible for iron transport in the bloodstream. Ferritin acts as an indicator of the total iron reserves in the body, primarily stored in the liver, spleen, and bone marrow. Transferrin levels, on the other hand, can give insights into the body's iron-carrying capacity, and its measurement can help diagnose conditions related to iron deficiency or overload. Together, these tests are crucial in diagnosing a range of conditions, from iron-deficiency anemia to hemochromatosis, and they offer valuable insights into the body's iron metabolism and overall health.
Fluid biochemistry refers to the comprehensive analysis of various body fluids, including cerebrospinal fluid (CSF) and urine, to determine their chemical constituents and evaluate overall health. Cerebrospinal fluid, the clear fluid found in the brain and spinal cord, plays a vital role in protecting the central nervous system. Its analysis can provide crucial insights into neurological conditions, infections, or diseases like multiple sclerosis. On the other hand, urine biochemistry focuses on assessing kidney function, hydration status, and potential metabolic disorders. By examining the concentration of substances such as proteins, glucose, and electrolytes in these fluids, healthcare professionals can diagnose, monitor, and manage various medical conditions, ensuring timely intervention and optimal patient care.
Blood glucose levels refer to the concentration of sugar present in the bloodstream, which is crucial for diagnosing and monitoring diabetes and other metabolic conditions. Various tests measure these levels to provide insights into an individual's sugar metabolism over different time frames. HBA1c, or Hemoglobin A1c, gauges average blood sugar levels over the past two to three months by assessing the percentage of glucose attached to hemoglobin, the oxygen-carrying protein in red blood cells. FBS, or Fasting Blood Sugar, measures glucose levels after an 8 to 12-hour fast, offering a snapshot of sugar levels in a fasting state. RBS, Random Blood Sugar, tests sugar levels without any fasting requirement, giving an immediate reading regardless of when the last meal was consumed. Finally, the OGTT, Oral Glucose Tolerance Test, evaluates the body's ability to process sugar by monitoring blood glucose levels before and after the ingestion of a glucose-rich solution. Together, these tests provide comprehensive information about an individual's glucose metabolism and potential insulin resistance or deficiencies.
Lipase is a vital enzyme primarily produced by the pancreas and, to a lesser extent, by the stomach and liver. It plays a crucial role in the digestive process, specifically in the breakdown of dietary fats into their constituent fatty acids and glycerol, facilitating their absorption within the small intestine. When fats are consumed, they're first emulsified by bile, after which lipase acts on these emulsified fats, rendering them suitable for absorption and utilization by the body. In addition to its digestive function, lipase is also used as a clinical marker: elevated levels in the blood can indicate pancreatic inflammation or injury, such as in conditions like pancreatitis. Given its essential role in digestion and its significance in medical diagnostics, lipase remains a critical enzyme for both physiological well-being and clinical assessment.
Uric acid is a naturally occurring waste product formed during the breakdown of purines, which are organic compounds present in certain foods and in the body's cells. The kidneys play a vital role in filtering uric acid from the bloodstream, excreting it through urine. While a certain amount of uric acid in the blood is normal and even beneficial, excessively high levels can lead to health complications. Elevated uric acid concentrations, known as hyperuricemia, may result in the formation of urate crystals in joints, leading to a painful condition called gout. Additionally, high uric acid levels have been associated with other conditions, including kidney stones and cardiovascular diseases. Monitoring and maintaining balanced uric acid levels is crucial for overall health, as it can help prevent and manage potential associated ailments.
Cancer markers, also known as tumor markers, are substances, often proteins, that are produced by the body in response to cancer growth or by the cancer tissue itself. Their presence in elevated amounts can be indicative of specific types of malignancies. Among these markers are AFP (Alpha-fetoprotein), commonly used to detect liver cancers; CA125, an indicator for ovarian cancer; CA15-3 and CA19-9, which can signal breast and pancreatic cancers respectively; and CEA (Carcinoembryonic antigen), which is associated with colon and rectal cancers. Additionally, Free PSA and Total PSA are markers for prostate health, with elevated levels potentially indicating prostate cancer. These markers play a crucial role in cancer diagnosis, prognosis, and in monitoring the effectiveness of treatment. It's essential to note that while an elevated level of a tumor marker may suggest the presence of cancer, it is not definitive on its own and should be used in conjunction with other diagnostic tests.
Cardiac biomarkers are vital indicators used primarily in the diagnosis and management of heart-related conditions, notably acute coronary syndromes. Among these, B-type Natriuretic Peptide (BNP) is crucial for assessing and managing heart failure, as elevated levels indicate increased cardiac stretch and ventricular dysfunction. Creatine Kinase MB (CKMB) is an enzyme found mainly in the heart muscle and is released into the bloodstream after cardiac injury, making it a valuable marker for myocardial infarction or heart attack. Myoglobulin, an oxygen-binding protein found in cardiac and skeletal muscles, is one of the earliest markers to rise following a heart attack, though it is less specific to cardiac injury. Lastly, High Sensitive Troponin I is a protein found in cardiac muscle and is highly specific to heart tissue. Its presence in the bloodstream, especially in elevated amounts, is a strong indicator of heart muscle injury. Collectively, these biomarkers play a pivotal role in the rapid and accurate diagnosis of cardiac events, facilitating timely and appropriate therapeutic interventions.
Fertility is a complex interplay of various hormones, each playing a crucial role in the reproductive processes of the human body. Oestradiol is a form of estrogen, the primary female sex hormone, vital for the menstrual cycle and reproductive development. FSH (Follicle Stimulating Hormone) and LH (Luteinizing Hormone) are released by the pituitary gland and regulate the ovaries in females and the testes in males. BHCG (Beta-Human Chorionic Gonadotropin) is significant for detecting pregnancy as its levels rise early during pregnancy. AMH (Anti-Müllerian Hormone) provides insights into ovarian reserve, essentially predicting a woman's remaining egg supply. Progesterone is pivotal for preparing the uterine lining for a fertilized egg's implantation and maintaining early pregnancy. Prolactin affects reproductive health by inhibiting FSH and GnRH, hormones essential for ovulation and menstruation. SHBG (Sex Hormone Binding Globulin) regulates the body's balance of testosterone and oestradiol. Lastly, Testosterone, commonly associated as a male hormone, also plays a role in female reproductive health, influencing libido and ovarian function. Monitoring the levels of these hormones is crucial in assessing fertility health, diagnosing potential disorders, and guiding treatments in reproductive medicine.
Metabolic tests, including VITB12, Cortisol, Folate, Insulin, Vitamin assays, and Anti-CCP, are essential diagnostic tools that provide insights into an individual's metabolic health and functioning. Vitamin B12 and Folate tests assess the levels of these crucial vitamins in the bloodstream, which play a pivotal role in cellular metabolism, DNA synthesis, and red blood cell formation. Cortisol tests measure the amount of this vital stress hormone, indicative of adrenal function and stress response. Insulin tests evaluate the body's ability to produce and respond to insulin, essential for glucose metabolism. Other vitamin assays detect deficiencies or excesses that can impact overall health. Meanwhile, the Anti-CCP test is specifically used to detect cyclic citrullinated peptide antibodies, often present in patients with rheumatoid arthritis. Together, these tests offer a comprehensive view of metabolic and immune system health, guiding clinicians in diagnosis, treatment, and preventive care.
The thyroid is a vital gland located in the neck that produces and secretes hormones crucial for regulating a plethora of bodily functions, including metabolism, heart rate, and body temperature. Among the essential thyroid hormones are Triiodothyronine (T3) and Thyroxine (T4). Both T3 and T4 exist in two forms: "Free", which is biologically active and unbound to proteins, and "Total", which includes both the free and protein-bound forms. The Thyroid Stimulating Hormone (TSH) is produced by the pituitary gland and plays a pivotal role in regulating the production of thyroid hormones. Additionally, Anti-Thyroglobulin (Anti-TG) and Anti-Thyroid Peroxidase (Anti-TPO) are antibodies that, when present in elevated levels, are indicative of certain autoimmune thyroid disorders, such as Hashimoto's thyroiditis or Graves' disease. Monitoring the levels of these hormones and antibodies provides invaluable insights into the health and functionality of the thyroid gland, aiding in the diagnosis, treatment, and management of various thyroid-related disorders.
The HIV Ag/Ab Combo (Quantitative) test, often referred to as the "fourth-generation" HIV test, represents a significant advancement in HIV diagnostics. This test simultaneously detects both the antigen (p24) and antibodies (Ab) specific to HIV-1 and HIV-2. The p24 antigen is a core protein of the HIV virus and can be detected in the blood shortly after infection, even before the body starts producing HIV antibodies. Consequently, the combination of antigen and antibody detection in a single test allows for earlier and more accurate identification of HIV infections. Quantitative results provide clinicians with a precise concentration of the detected markers, offering insights into the progression of the infection and aiding in patient management decisions. By leveraging this dual-detection methodology, the HIV Ag/Ab Combo test plays a crucial role in improving the early diagnosis of HIV, facilitating timely interventions, and enhancing patient care outcomes.
The HIV viral load refers to the amount of HIV present in a blood sample of an infected individual. It is a crucial metric used to assess the severity of HIV infection and the effectiveness of antiretroviral therapy (ART). A high viral load indicates active viral replication and suggests that the immune system is not effectively controlling the infection. Conversely, a low viral load is a positive sign, indicating that the immune system is successfully suppressing the virus, often aided by ART. Regular monitoring of the HIV viral load helps healthcare professionals make informed decisions about treatment strategies, track the progression of the disease, and predict potential transmission risks. It's worth noting that achieving an undetectable viral load significantly reduces the risk of transmitting HIV to others, though it doesn't mean the virus is eradicated from the body.
HIV DNA PCR is a molecular diagnostic test that detects the presence of HIV DNA in a patient's blood cells, specifically targeting the viral genetic material rather than the antibodies or antigens. This test is especially valuable in specific situations, such as diagnosing HIV in newborns born to HIV-positive mothers. Since infants retain their mother's antibodies for several months, traditional HIV antibody tests can yield false-positive results. By targeting the virus's DNA directly, PCR offers a more definitive diagnosis. Additionally, because the PCR method can detect the virus soon after exposure, it's also used for early HIV detection in adults, before antibodies have developed. Accurate and rapid, HIV DNA PCR plays a crucial role in early intervention and management of HIV, enabling timely treatment and reducing the risk of complications.
Mycobacterium Tuberculosis PCR is a molecular diagnostic technique used to detect the presence of Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), in clinical samples. Utilizing the principles of polymerase chain reaction (PCR), this method amplifies specific DNA sequences unique to M. tuberculosis, allowing for rapid and highly sensitive detection. Traditional methods of TB diagnosis, such as culture techniques, can take weeks to yield results, whereas PCR can provide results within hours. As early detection and treatment are critical in managing TB and preventing its spread, Mycobacterium Tuberculosis PCR has become an invaluable tool in the timely diagnosis of this infectious disease, especially in cases where patients may not exhibit clear symptoms or in the detection of drug-resistant strains.
The CTNG PCR test is a sophisticated diagnostic tool utilized for the simultaneous detection of three common sexually transmitted infections (STIs): Chlamydia trachomatis, Trichomonas vaginalis, and Neisseria gonorrhoeae. These pathogens are responsible for conditions such as chlamydia, trichomoniasis, and gonorrhea, respectively. Utilizing the precision of polymerase chain reaction (PCR) technology, this test amplifies the DNA of these pathogens, enabling highly accurate detection even in samples with low bacterial or parasitic loads. Being a rapid and reliable method, the CTNG PCR test is instrumental for clinicians in promptly diagnosing and treating these infections, thereby reducing the risk of complications and further transmission.
HPV, or Human Papilloma Virus, represents a diverse group of DNA-based viruses that infect the skin and mucous membranes of humans. Among the many strains of HPV, types 16, 18, and 45 are of particular concern as they are classified as high-risk strains, closely associated with the development of cervical cancer and other types of genital cancers. While HPV infections are often asymptomatic and can resolve spontaneously, persistent infections by high-risk strains like 16, 18, and 45 can lead to cellular changes, increasing the risk of malignancies. It is crucial to monitor and manage infections with these strains due to their potential implications on human health. With preventive measures like HPV vaccines and regular screenings, the risks associated with these strains can be significantly reduced.
The SARS-CoV-2 PCR (Polymerase Chain Reaction) test is a molecular diagnostic procedure used to detect the presence of the SARS-CoV-2 virus, the causative agent of COVID-19. By amplifying and analyzing specific genetic segments of the virus, this test provides a highly accurate indication of an active infection. Since the PCR technique is sensitive enough to detect even low amounts of viral RNA, it has become the gold standard for COVID-19 testing. Early detection through the SARS-CoV-2 PCR test plays a pivotal role in timely treatment, isolation, and the prevention of potential transmission, making it a crucial tool in the global effort to combat the pandemic.
Trichomonas Vaginalis PCR is a molecular diagnostic test that detects the presence of the parasite Trichomonas vaginalis in a patient's sample, typically collected from the urogenital tract. Trichomonas vaginalis is a protozoan parasite responsible for trichomoniasis, one of the most common sexually transmitted infections worldwide. The PCR (Polymerase Chain Reaction) method amplifies the DNA of the parasite, allowing for highly sensitive and specific detection, even in individuals with low parasite loads. Compared to traditional diagnostic methods, such as microscopic examination, the Trichomonas Vaginalis PCR offers superior accuracy, rapid results, and the ability to detect co-infections when combined with other tests. As a result, it plays a crucial role in the timely diagnosis and treatment of trichomoniasis, helping to reduce the risk of complications and further transmission.